Johnson & Johnson Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Higi House, Opp. Ralli Wolf, L.B.S. Marg, Mulund (W), Mumbai, MH 400080, India (IND)
- Operations here
- analysis
- FDA identifiers
- FEI 3007543295 · DUNS 677603030
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-04-30
- NAIDrug Quality Assurance2019-07-10
- NAIDrug Quality Assurance2014-05-28
- NAIDrug Quality Assurance2010-10-15
Drugs this plant is listed as making
13 distinct drugs across 25 products name this site in their FDA label.
- abiraterone acetateJanssen Biotech, Inc.
- canagliflozin and metformin hydrochlorideJanssen Pharmaceuticals, Inc.
- ErdafitinibJanssen Products LP
- etravirinePatriot Pharmaceuticals
- gemcitabine intravesicalJanssen Biotech, Inc
- icotrokinraJanssen Biotech, Inc.
- lazertinibJanssen Biotech, Inc.
- macitentanActelion Pharmaceuticals US, Inc.
- macitentan and tadalafilActelion Pharmaceuticals US, Inc.
- NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATEJanssen Biotech, Inc.
- rilpivirine hydrochlorideJanssen Products, LP
- rivaroxabanJanssen Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.